Starboard 13-F
Newsquawk Staff ·
- Cut: Riot (RIOT), News (NWSA).
What it means
A 13-F is a backward-looking snapshot, disclosing positions as of quarter end with a lag that can run to several weeks, so any reduction shown may predate recent price action in the names. Starboard's track record is that of an activist that builds stakes to press for operational or strategic change, which makes cuts worth reading two ways: routine trimming of a passive position carries little signal, while an exit from a name where the fund had been agitating marks the end of a campaign and removes a buyer with a stated agenda. Riot and News Corp are very different situations, the former a volatile, operationally geared name where activist involvement has historically centred on capital allocation and strategy, the latter a controlled company where outside investors have limited leverage given the dual-class structure. The tells are whether the cuts are partial or full exits, whether an amended 13-D or 13-G follows with commentary, and whether the fund's remaining book shows capital rotating into a new target. Filing season tends to produce a cluster of such disclosures, and the pattern in past cycles is that single cuts draw little lasting reaction unless they signal abandonment of an active thesis.
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation
- American Express (AXP) to cut 5% of jobs
- US BROKER MOVES: HESM upgraded at Raymond James; NCLH downgraded at JPM
Related headlines
- Oracle (ORCL) to invest USD 1bln in partner ecosystem over 4 years2 hours ago
- Bristol-Myers Squibb (BMY) says Iza-Bren reduced the risk of progression or death by 59% in Phase 3 breast cancer study; median PFS 8.2 months vs 4.0 months for chemotherapy; cORR 40.5% vs 20.2%; mDOR 6.9 vs 4.2 months2 hours ago
- American Express (AXP) Q3 2026 (USD): EPS 5.42 (exp. 4.50), Revenue 20.1bln (exp. 20.1bln)2 hours ago
- Booz Allen (BAH) Q2 2026 (USD): Adj. EPS 1.76 (exp. 1.48), Revenue 2.80bln (prev. 2.81bln)3 hours ago
- SLB (SLB) Q3 2026 (USD): adj. EPS 0.64 (exp. 0.62), Revenue 9.45bln (exp. 9.27bln)3 hours ago
- Citi (C) has been granted approval by China for its securities unit5 hours ago
- Tesla (TSLA) has decided not to proceed with plans to produce Cybertruck for Australia and New Zealand13 hours ago
- OpenAI trims valuation target to USD 1.25tln after previously pitching a higher price, according to FT15 hours ago
- Newmont (NEM) says production growth is expected to begin in 2027 following previously flagged 2026 trough, adds Q3 gold production was broadly flat sequentially as anticipated16 hours ago
- SpaceX (SPCX) in talks to access 80,000 cell sites for new network16 hours ago
- Google (GOOG) announces general availability of an Anthropic-managed deployment option for Claude models on Google Cloud16 hours ago
- OpenAI is raising up to USD 30bln in funding round at a USD 1.25tln valuation, led by UAE investors, according to CNBC, citing sources; OpenAI is negotiating a commercial deal that would secure more computing capacity from the UAE17 hours ago
- Gilead Sciences (GILD) entered into a definitive agreement to acquire an oral IL-23R inhibitor program, including lead asset HCXT-2001, from PepStar Therapeutics Limited; deal valued at USD 1.27bln in upfront cash17 hours ago
- Newmont (NEM) Q3 2026 (USD): Adj. EPS 2.20 (exp. 2.06), Revenue 6.36bln (exp. 6.30bln), Adj. EBITDA 3.95bln (exp. 3.73bln)17 hours ago
- Bloom Energy (BE) Q3 2026 (USD): Adj. EPS 0.94 (exp. 0.69), Revenue 1.24bln (exp. 1.06bln)17 hours ago